← Leaderboards
Christopher Seet
University Of California Los Angeles
$1,554,283
Attributed
$1,554,283
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $569.9K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,554,283 · 2
By mechanism
K08$984,420 · 1
R37$569,863 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Margaret Goodell$39,279,889
- Dong Sung An$9,622,627
- Tom Chou$3,256,777
- Christel H. Uittenbogaart$7,202,932
- Z Hong Zhou$29,087,466
Others in their field
Other Emerging Leaders on “Tumor”
- Leonard Freedman · Leidos Biomedical Research, Inc.$360,535,780
- Lynn Briscoe · Leidos Biomedical Research, Inc.$120,794,323
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$105,180,681
- Leonard Freedmand · Leidos Biomedical Research, Inc.$78,762,245
- Connie Suders · Leidos Biomedical Research, Inc.$67,882,919
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
Research focus
TumorGenerationsSourceCancer TherapyPeripheral BloodOrganoidsIn VitroPropertyT-LymphocyteAntigensBloodThymus GlandAutologousAntigen-Specific T CellsCd8-Positive T-LymphocytesBaltimoreAffinityClone CellsCloningCollaborationsCancer ImmunotherapyAntigen PresentationAutoantigensCell Mediated Immune Response
Grant awards (6)
Death receptor signaling as an immune checkpoint in tumor-specific iPSC-T cell function$569,863
R37 · FY2025 · CA · contact PI
Development of a novel platform for the discovery of antigen-specific TCRs$196,884
K08 · FY2023 · CA · contact PI
Development of a novel platform for the discovery of antigen-specific TCRs$196,884
K08 · FY2022 · CA · contact PI
Development of a novel platform for the discovery of antigen-specific TCRs$196,884
K08 · FY2021 · CA · contact PI
Development of a novel platform for the discovery of antigen-specific TCRs$196,884
K08 · FY2020 · CA · contact PI
Development of a novel platform for the discovery of antigen-specific TCRs$196,884
K08 · FY2019 · CA · contact PI